Clinical and Therapeutic Approach to Hospitalized COVID-19 Patients: A Pediatric Cohort in Portugal

Clinical and Therapeutic Approach to Hospitalized COVID-19 Patients: A Pediatric Cohort in Portugal

Introduction: Coronavirus disease 2019, or COVID-19, in children is usually a mild disease, but severe illness has been reported. Currently, the therapy benefits of antiviral experimental drugs are still uncertain. The main aim of this study is to describe the experience of a level III hospital rega...

Full description

Bibliographic Details
Main Authors:	Bárbara Martins Saraiva, Ana Margarida Garcia, Tiago Milheiro Silva, Catarina Gouveia, Maria João Brito
Format:	Article
Language:	English
Published:	Ordem dos Médicos 2021-03-01
Series:	Acta Médica Portuguesa
Subjects:	antiviral agents/therapeutic use child covid-19 portugal sars-cov-2
Online Access:	https://actamedicaportuguesa.com/revista/index.php/amp/article/view/15360

Similar Items

The Potential of Antiviral Peptides as COVID-19 Therapeutics
by: Arun Suria Karnan Mahendran, et al.
Published: (2020-09-01)

COVID-19 Therapeutic Options Under Investigation
by: Malak Kaddoura, et al.
Published: (2020-08-01)

The Contribution of SARS-CoV-2 Genomics to the Handling of the COVID-19 Pandemic in Portugal
by: João Paulo Gomes
Published: (2021-06-01)

Therapeutic Strategies Against COVID-19 and Structural Characterization of SARS-CoV-2: A Review
by: Gi Uk Jeong, et al.
Published: (2020-07-01)

Natural Bioactive Molecules as Potential Agents Against SARS-CoV-2
by: Wei Chen, et al.
Published: (2021-08-01)

Emerging Therapeutic Approaches to Combat COVID-19: Present Status and Future Perspectives
by: Karthik Vivekanandhan, et al.
Published: (2021-03-01)

Origin, structural characteristics, prevention measures, diagnosis and potential drugs to prevent and COVID-19
by: Norma Francenia Santos-Sánchez
Published: (2020-09-01)

Potential therapeutic use of RNA interference against COVID-19
by: Dany A. Cuello-Almarales, et al.
Published: (2020-06-01)

Experience of a Portuguese Center: Effectiveness of Direct-Acting Antiviral Therapy for Hepatitis C
by: Fátima Falcão, et al.
Published: (2019-03-01)

Antiviral and Immunomodulatory Effects of Phytochemicals from Honey against COVID-19: Potential Mechanisms of Action and Future Directions
by: Mohammad A. I. Al-Hatamleh, et al.
Published: (2020-10-01)

Antiviral and immunomodulatory activity of curcumin: A case for prophylactic therapy for COVID-19
by: Rajesh K. Thimmulappa, et al.
Published: (2021-02-01)

GRL-0920, an Indole Chloropyridinyl Ester, Completely Blocks SARS-CoV-2 Infection
by: Shin-ichiro Hattori, et al.
Published: (2020-08-01)

Health Literacy of the Inland Population in Mitigation Phase 3.2 of the COVID-19 Pandemic in Portugal: A Descriptive Cross-Sectional Study
by: Joana Gomes da Silva, et al.
Published: (2020-12-01)

Experimental Antiviral Therapeutic Studies for Human Rhinovirus Infections
by: Coultas JA, et al.
Published: (2021-07-01)

Silver-Based Nanomaterials as Therapeutic Agents Against Coronaviruses: A Review
by: Das C, et al.
Published: (2020-11-01)

3D Cell Culture Models in COVID-19 Times: A Review of 3D Technologies to Understand and Accelerate Therapeutic Drug Discovery
by: Guadalupe Tonantzin de Dios-Figueroa, et al.
Published: (2021-05-01)

Coronavirus (SARS-CoV-2): Preventions, keys to diagnosis and treatment of SARS-CoV-2
by: Kuldeep Singh Patel, et al.
Published: (2020-03-01)

Plitidepsin: Mechanisms and Clinical Profile of a Promising Antiviral Agent against COVID-19
by: Michail Papapanou, et al.
Published: (2021-07-01)

Valinomycin as a potential antiviral agent against coronaviruses: A review
by: Dong Zhang, et al.
Published: (2020-10-01)

Ciclesonide Inhaler Treatment for Mild-to-Moderate COVID-19: A Randomized, Open-Label, Phase 2 Trial
by: Joon-Young Song, et al.
Published: (2021-08-01)

Novel Binding Mechanisms of Fusion Broad Range Anti-Infective Protein Ricin A Chain Mutant-Pokeweed Antiviral Protein 1 (RTAM-PAP1) against SARS-CoV-2 Key Proteins in Silico
by: Yasser Hassan, et al.
Published: (2020-09-01)

Development of cell-based pseudovirus entry assay to identify potential viral entry inhibitors and neutralizing antibodies against SARS-CoV-2
by: Jie Hu, et al.
Published: (2020-12-01)

Potential therapeutic agents to COVID-19: An update review on antiviral therapy, immunotherapy, and cell therapy
by: Mona Sadat Mirtaleb, et al.
Published: (2021-06-01)

Initial Assessment of the Impact of the Emergency State Lockdown Measures on the 1st Wave of the COVID-19 Epidemic in Portugal
by: Vasco Ricoca Peixoto, et al.
Published: (2020-11-01)

Alkaloids: Therapeutic Potential against Human Coronaviruses
by: Burtram C. Fielding, et al.
Published: (2020-11-01)

IFN-α and β restrict JC virus replication in primary human fetal glial cells : implications for progressive multifocal leukoencephalopathy therapy
by: Co, Juliene Kimberly G
Published: (2011)

Emerging Therapeutic Modalities against COVID-19
by: Shipra Malik, et al.
Published: (2020-08-01)

Interferon-β: treatment option against COVID-19
by: Faiz Ul haq, et al.
Published: (2020-07-01)

Baicalein and Baicalin Inhibit SARS-CoV-2 RNA-Dependent-RNA Polymerase
by: Keivan Zandi, et al.
Published: (2021-04-01)

Therapeutic challenges of COVID-19: strategies of empirical treatment
by: Ahmed Hasan Mohammed, et al.
Published: (2020-12-01)

Antiviral Activity of Umifenovir In Vitro against a Broad Spectrum of Coronaviruses, Including the Novel SARS-CoV-2 Virus
by: Irina Leneva, et al.
Published: (2021-08-01)

Vitamin D Supplementation: A Potential Approach for Coronavirus/COVID-19 Therapeutics?
by: John F. Arboleda, et al.
Published: (2020-06-01)

Case Series of 103 Children with SARS-CoV-2 Infection in Portugal
by: Clara Picão de Carvalho, et al.
Published: (2020-12-01)

Indian Herb-Derived Phytoconstituent-Based Antiviral, Antimicrobial and Antifungal Formulation: An Oral Rinse Candidate for Oral Hygiene and the Potential Prevention of COVID-19 Outbreaks
by: Shashwat Sharad, et al.
Published: (2021-09-01)

Important Roles of Oligo- and Polysaccharides against SARS-CoV-2: Recent Advances
by: Siavash Iravani, et al.
Published: (2021-04-01)

Medicinal Plants, Phytochemicals, and Herbs to Combat Viral Pathogens Including SARS-CoV-2
by: Arumugam Vijaya Anand, et al.
Published: (2021-03-01)

SARS-CoV-2 Cellular Infection and Therapeutic Opportunities: Lessons Learned from Ebola Virus
by: Jordana Muñoz-Basagoiti, et al.
Published: (2021-01-01)

Therapeutic development by repurposing drugs targeting SARS-CoV-2 spike protein interactions by simulation studies
by: Qazi Mohammad Sajid Jamal, et al.
Published: (2021-08-01)

Evaluation of Current Therapies for COVID-19 Treatment
by: Atin Sethi, et al.
Published: (2020-07-01)

Management of therapeutic unfractionated heparin in COVID‐19 patients: A retrospective cohort study
by: Lachelle D. Weeks, et al.
Published: (2021-05-01)